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Abstract
In this study, we are examining the effect of the length and polarity of peptide
linker arms on the performance of enzyme - analyte conjugates in a reagent-
limited heterogeneous immunoassay which utilizes a solid phase format. In our
model system, our goal is to attach benzoylecgonine, the primary urinary
metabolite of cocaine, to glucose oxidase by a series of peptide linker arms.
Peptide linker arms were synthesized using the fluorenylmethoxycarbonyl
(Fmoc) solid phase peptide synthesis strategy described by Stewart and Young
(1). We attached the BEC to the exposed amino - terminal end of the peptide
linker arm by the free carboxyl group of BEC prior to removal of the peptide from
the solid phase to avoid the requirement for isolation of the peptide before
reacting with the analyte. The BEC-peptide will be activated by the mixed
anhydride method (2) and coupled to glucose oxidase. The BEC
- peptide can
also be conjugated to the carbohydrate portion of glucose oxidase using
peptides containing carboxy
- terminal hydrazides.
The enzyme-analyte conjugates will be characterized immunochemically to
determine the effect of the linker arm on conjugate performance in an
immunoassay. We will focus mainly on the following three factors: binding of the
conjugate to the antibody in the absence of benzoylecgonine; displacement of
the bound enzyme - analyte conjugate by the physiological concentrations of the
analyte; and non
- specific binding.
It is expected that the enzyme analyte conjugate containing the linker arm
system should give better binding of the antibody to the enzyme - analyte than
the one without any linker arm. This system for binding an analyte to an enzyme
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In this study, we are examining the effect of the length and polarity of peptide
linker arms on the performance of enzyme - analyte conjugate in a reagent-
limited heterogeneous immunoassay which utilizes a solid phase format. In our
model system, our goal is to attach benzoylecgonine (see fig. 1 ), the primary
urinary metabolite of cocaine, to glucose oxidase by a series of peptide linker
arms (see fig. 2).
The concentration of small molecules in physiological fluids is often determined
by a competitive immunoassay - an analytical procedure based on the reversible
binding of an analyte to an antibody. The labeled analyte is mixed with the test
solution containing an unknown amount of the analyte. The solution containing
the labeled and unlabeled analyte reacts with a limited amount of antibody
bound to a solid surface.
A variety of methods have been developed to measure either the bound or
unbound forms of the labeled analytes. A homogenous assay approach does not
require the separation of the bound and free labeled analyte because they can
be directly distinguished from one another. The enzymatic activities of the label
are changed because of the binding of the antibody to the enzyme-labeled
analyte. In most instances, binding of antibody to the enzyme
- analyte
conjugate inhibits the enzyme by limiting the substrate's access to the catalytic
site. A good example is the gentamicin assay (4). The measurement of thyroxin
(T4) is based on the competition between serum T4 and enzyme-labeled T4 for
the limited binding sites on the thyroxin antibody. The enzyme label, malate
dehydrogenase, becomes inactive once it binds to T4 because the active site is
blocked by T4 . The activity of the enzyme increases in the presence of T4
antibody because T4 binds to the antibody and therefore is displaced from the
active sites (4).
On the other hand, a heterogeneous assay requires the separation of the bound
and free labeled analyte. Some techniques, such as nonspecific absorbents,
specific absorbents, chromatography, salt precipitation, and double antibody
precipitation have been used to perform the separations. The concentration of
the analyte then is inversely proportional to the signal produced by the labeled
analyte that still binds to the antibody. In some assays, the labeled enzyme -
analyte does not produce signals. Therefore, the concentration of analyte is
determined by the free form of the labeled analyte.
Consequently, successful conjugation between analytes of interest (such as
drugs, hormones, environmental toxins, cell surface antigens, and fragments of
viral coat proteins) and reporter groups (such as enzymes, dyed or magnetic
particles, or colloidal gold) is essential to the development of new analytical
methods, new therapeutic reagents, and many other areas of biomedical
research. Because it will provide a great body of information which could not
have been obtained by other methods.
The most commonly used signal generators for an immunoassay are
radioisotopes, enzymes, and fluorophores. During recent years, competitive
immunoassays based on enzymes and fluorescent labels have become more
popular due to the increasing awareness of the inherent difficulties in generation
and disposal of radioactive waste. Signal amplification by an enzyme label is
achieved by rapid turnover of substrate to form colored, fluorescent, or
luminescent products. The reactions can be photometrically monitored.
When using an enzyme label for small analytes such as drugs of abuse, the
challenge is to insure that the attached analyte is not sterically hindered from
interaction with antibodies. Usually, the analyte attached to an enzyme is so
small that it may be buried within the enzyme and therefore cannot interact with
antibodies (see fig. 3). Hence, the thought is that the conjugated analyte could
be attached to the enzyme through a linker arm to be extended away from the
surface of the enzymes. As a result, it could more effectively compete with the
free analyte in solution.
Linker arms have been used in a wide variety of biological applications. They
are often necessary to preserve the biological activity of two proteins that are
cross - linked. This was demonstrated in cases of a carbohydrate linker arm that
was used to conjugate two enzymes (5).The Chitin Lash was used to crosslink
staphylococcal nuclease to ribonuclease A with retention of 75% and 78%,
respectively, of the starting enzyme activities.
Different peptide linker arms have been used to influence the local environment
of immobilized enzymes (6). In this study, polypeptide arms of known
composition were quantitatively grafted to alcohol dehydrogenase. The
properties of the microcavity of the gel, in which the enzyme is immobilized by
multipoint covalent linkages, are fully determined by the linker arms. According
to the article, the results obtained using the soluble preparation indicate that the
chemical activation by itself (alcohol dehydrogenase) does not induce any
modification of the activation energy of the reaction, whereas the grafting of a
complete peptide induces a rise of this value for the two hydrophilic peptides.
The grafting of only one amino acid (Alcohol dehydrogenase
-
Homocystine)
induces a slightly lower value. This can be explained by the possible dynamic
interactions between the two hydrophilic peptides and the outer layer of the
enzyme. These interactions could stablize the outer layer of the protein . As a
result, the transconformational mobility of the protein could be inhibited to a
certain extent and that would lead to a higher activation energy of the reaction.
Peptide linker arms have also been found to affect the metabolism and
biodistribution of antibody
- analyte conjugates (7). Studer et al., compared two
kinds of antibody-conjugated benzyl - EDTA: one had a peptide linker arm:( Ala
-
Leu - Ala - Leu) whereas the other conjugate did not. Digestion of the benzyl -
EDTA with linker arm and without linker arm in vivo showed that the conjugate
containing the linker arm was cleaved at the liver more rapidly by the liver
protease cathepsin B1 (T1/2=6 h) than the other conjugate, which had 79%
radioactivity still attached to the protein after 97h of exposures to cathepsin B1.
Indeed, the result indicated that the rate of clearance by liver depends on the
linker. Furthermore, the excretion rate of the conjugate containing the linker arm
was faster than the one which lacked this feature.
Optimal linker arm lengths have been identified for improving the efficacy of
inhibitors of human leukocyte elastase (8) and inhibitors of chloride -
transporting systems in membranes (9). It was demonstrated that the human
leukocyte elastase inhibitory potency of derivatives of benzisothiazolinone 1,1-
dioxide (saccharin) N - acetylated with aliphatic and aromatic substituted acyl
groups increased as a function of their carbon chain length. The result indicated
that macromolecular conjugates were demonstrably inhibitory to red blood cell
anion exchange when the ligands were appropriately coupled: inhibitory efficacy
strongly depended on the chemical structure of the coupled ligand and the
spacer length between the inhibitory moiety and the macromolecule.
Similarly, by increasing the length of the alkyl linker arms in derivatives of the (3 -
adrenergic drug, isoproterenol, the potency of these derivatives was increased
in an in vitro assay (10). Reitz et al., found that a benzyl carbonate derivative
containing a branched, seven-carbon spacer group was 40 times more potent
than isoproterenol in the in vitro assay.
Finally, linker arms have been used to improve the sensitivity of a quantitative
assay for specific ribonucleic acid sequences (11). Improved hybridization
behavior was noted by increasing the length of the alkyl spacer of the
oligonucleotide-alkaline phosphatase conjugate. The enzyme moiety was
separated from the nucleic acid by ethylene or hexene. A two - fold increase in
signal - to - background ratio was observed for the detection of the probe having
a six-carbon spacer between the oligonucleotide and the enzyme.
Peptide chains are chosen as linker arms because numerous possibilities of
composition and properties (polar, non - polar, positively charged, negatively
charged, flexible and rigid) can be achieved through the choice of amino acids
and because solid phase peptide synthesis methods are well established .
Selection of appropriate enzyme for use as a label for the immunochemical
reagents is very often empirical, and each has distinct advantages and
disadvantages. Enzymes used as labels differ from radioisotopes in that the
binding reaction can modify their activity. Consequently, enzymes can be used
as labels only when they satisfy the following criteria (4):
1 . The enzymes must have a very high specific activity. The signal amplification
seen with enzymes is related to the amount of substrate converted to product
during the time of incubation. Enzymes with the highest specific activities are
potentially capable of giving the greatest amplification. Assays using such
enzymes are able to detect very low concentrations of analytes.
2. The labels must be stable during the assay and under refrigerated storage
conditions.
3. The enzymes must not be present in the biological fluid or tissue sample that
is to be analyzed. Contaminating label in the biological fluid would increase
background, decrease the sensitivity, and give false positives.
4. The enzymes must retain most of their activity when attached to the antibody.
Glucose oxidase
(GO1
) is considered an ideal enzyme for biosensor
development (12) and has been used as the enzyme label in steroid
immunoassays (13). This enzyme has been used as the basis for glucose
sensors in some glucose detection kits. It catalyzes the oxidation of (3-D-glucose
to glucono-8-lactone and the reduction of molecular oxygen to hydrogen
peroxide (equation 1).
glucose oxidase
glucose + 02 > gluconic acid + H202 (equ. 1 )
1
BEC. benzoylecgonine; DCC. dicyclohexylcarbodiimide; DCM, dichloromethane; DIEA.
diisopropylethlamine; DMF. dimethylformamide; Fmoc, fluorenylmethyoxycarbonyl; GO, glucose
oxidase; HOBt, N-hydroxybenzotriazole; NSB, non-specific binding.
The hydrogen peroxide produced from the glucose oxidase reaction is
consumed by a peroxidase-dye indicator reaction in which the oxidized dye is
colored, allowing the reaction to be photometrically monitored (equation 2).
peroxidase
H202 + reduced dye < > oxidized dye + H20 (equ. 2)
In our research, the substrate (reduced dye) 3,3',5,5'-tetramethylbenzidine will
be oxidized by horseradish peroxidase. The reaction can be detected at 410 nm.
Since a single molecule of enzyme can catalyze the turnover of many molecules
of substrate, the sensitivity of the assay could be improved .
Glucose oxidase is selected from among other potential enzyme labels based on
its excellent stability (14), particularly in lyophilized preparation. Lyophilized
glucose oxidase is stable for 2 years at 0C. Additionally, there are 14 lysine
residues per subunit (15) of glucose oxidase, most of which are likely to be
found on the enzyme surface where they could be available as attachment sites
for the BEC-peptide.
Our first approach is to couple the BEC
- peptide to glucose oxidase by forming
an amide bound between the carboxy end of the peptide linker arm and the
amino terminal of the lysine residues on glucose oxidase ( see fig. 4 ). Peptide
linker arms were synthesized using the fluorenylmethoxycarbonyl ( Fmoc ) solid
phase peptide synthesis strategy described by Stewart and Young (1). We
attached the BEC to the exposed amino - terminal end of the peptide linker arm
attached the BEC to the exposed amino - terminal end of the peptide linker arm
by the free carboxyl group of BEC prior to removal of the peptide from the solid
phase to avoid the requirement for isolation of the peptide before reacting with
the analyte ( method 1 ).
The BEC - peptide can also be conjugated to the carbohydrate portion of
glucose oxidase using peptides containing carboxy terminal hydrazides
( method 2, see fig. 5 ). BEC - peptide hydrazides can be prepared according to
the methods of Ramage et al. (3). The site - directed immobilization of antibodies
on hydrazide - containing solid supports following oxidation of their N
- linked
and O - linked carbohydrate moieties is well documented (16) The resulting
vicinal dialdehydes will react with the BEC - peptide hydrazides to form stable
hydrazone linkages.
Many factors need to be considered in the development of an immunoassay.
Major factors are: sensitivity, accuracy, specificity, et al.. The enzyme-analyte
conjugates we develop will be characterized immunochemically to determine the
effect of the linker arm on conjugate performance in an immunoassay. We will
focus mainly on the following three factors in assay performance which relate
specifically to enzyme
- analyte conjugates:
1. Binding of the conjugate to the antibody in the absence of benzoylecgonine.
The concentration of free analyte in solution is inversely proportional to the
antibody. To be effective in an immunoassay, the conjugate must bind with
sufficient affinity to the immobilized antibody to generate a colorimetric signal
of approximately 1.5 to 2.0 absorbance units in the absence of the free
analyte.
2. Displacement of the bound enzyme - analyte conjugate by the analyte. In a
competitive assay, the labeled analyte will compete with the free analyte in
physiological fluid. It is necessary to develop conjugates that can bind tightly
enough to the antibody to generate a detectable signal. On the other hand, it
should also be displaced by the analyte in a specified concentration range.
3. Non - specific binding ( NSB ) refers to the conjugates that are non -
specifically bound to the tube in the absence of antibody. The immunoaffinity






Glucose oxidase (Aspergillus niger) and horseradish peroxidase were from
Sigma Chemical Co. (St. Louis, MO). Resins and Fmoc-amino acids were from
Peptide International Inc. Benzoylecgonine was generously provided by the
Research Technology Branch of the National Institute on Drug Abuse (Research















































1. Synthesis of the Benzoylecgonine - Peptide Conjugate
Method 1 We used the Fmoc solid phase peptide synthesis strategy described
by Stewart and Young (1) with some modifications (see figure 6). The first
glycine residue was already attached to resin by its carboxyl end when
purchased and subsequent amino acid residues were attached at the amino
terminus of the growing peptide.
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At each cycle, the Fmoc-amino group was deprotected by a 20% piperidine/
DCM treatment followed by several washing steps. Pre-formed symmetrical
anhydrides (see figure 7) in DCM were mixed with the resin until monitoring
showed complete reaction. Symmetrical anhydrides were chosen because of
their high reactivities (2). They were prepared using 4 equivalents of protected
amino acid and 2 equivalents of DCC in 50% DMF. The urea produced was
removed by filtration. DIEA, a tertiary amine, was added (equivalent to the
amount of peptide on the resin) 15 minutes after the coupling reaction had
begun to accelerate the reaction. The coupling efficiency was checked during
each cycle using the Kaiser test (17).
The Kaiser test involves the following reagents: 5 g of ninhydrin in 100 ml
ethanol, 80 g of liquefied phenol in 20 ml ethanol, and 2 ml of 0.001 M aqueous
potassium cyanide in 98 ml of pyridine. A few resin beads were removed from
the mixing chamber, thoroughly washed with ethanol, and sampled with 2
drops
of each reagent above for 5 minutes at 120C. Yellow solution and white beads
indicated a complete coupling. Blue beads indicated an incomplete coupling.
The active ester method (see figure 8) was chosen to attach the BEC to the
peptide - resin. BEC was preactivated with DCC and N
- HOBt in high quality
DMF to form the HOBt active ester. For HOBt active esters, 5 equiv. of BEC ,
13
DCC and HOBt were used. The filtrate was reacted with the peptide-resin until
the Kaiser test gave a negative result.
At the end of the synthesis, the resin was shrunk by methanol or isopropanol
treatment. The BEC-peptide-resin was dried under vacuum for at least 4 hours
before cleavage. 82.5% trifluoroacetic acid aqueous solution was used to
release the conjugate from the resin. The filtrate was brought to dryness and
precipitated from cold ether. (For detailed synthesis protocol see Appendix A)
Method 2 (Peptides Containing Carboxy - Terminal Hydrazides) BEC
-
peptide hydrazides (see figure 6) were prepared by using Boc
- Gly O - Resin.
50% TFA/DCM was used as deprotection reagent. The peptide -0
- resin was
synthesized following the Fmoc peptide synthesis strategy described above. The
active ester coupling method was again used to attach BEC to peptide
-resin.
The peptide resin was then suspended in purified DMF (5 ml per g of resin) and
anhydrous hydrazine (30 equiv. per equiv. of peptide). The mixture was stirred
for 2 days at room temperature. Resin was removed by filtration and washed
with DMF. The combined filtrate and washings were evaporated in vacuum and
then were purified. (For detailed protocol see Appendix B)
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2. Purification of BEC - peptide
Our initial attempts to purify the BEC
- peptide involved cation exchange
chromatography . The use of volatile pyridine acetate buffers (18) would enable
us to lyophilize the isolated fractions to obtain salt-free BEC-peptide in
anhydrous condition.
Two buffers were prepared, the pH 3.1 0.2N pyridine acetate buffer and the pH
5.0 2.ON pyridine acetate buffer. All reagents were degassed. The Dowex-50X2
resin was swollen in pH 3.1 buffer at a ratio of 1 volume of resin to 2 volumes of
buffer. An HPLC pump, low pressure mixing valve and control module from the
Autochrom Co. were connected to the column to control the flow rate (1 ml/min )
and to run a gradient of the two buffers. The column was washed with 3 volumes
of the pH 3.1 buffer before the sample was applied.
The separation was initiated with pH 3.1 buffer. Elution conditions were:
Initial 1 00% pH 3. 1 buffer 1.0 ml/min
10 min 100% pH 3.1 buffer 1.0 ml/min
30 min 100% pH 5.0 buffer 1.0 ml/min
40 min 100% pH 5.0 buffer 1 .0 ml/min
50 min 1 00% pH 3. 1 buffer 1.0 ml/min




We attemped to analyze the purity of the crude sample by HPLC. Solution A
(0.1% TFA in water) and solution B (0.1% TFA in acetonitrile) were prepared.
Elution conditions were:
Initial 100% A 1.0 ml/min
10 min 100% A 1.0 ml/min linear gradient to
30 min 100% B 1.0 ml/min
40 min 100% B 1.0 ml/min linear gradient to
50 min 100% A 1.0 ml/min




A. Synthesis of the Benzoylecgonine - Peptide Conjugate
The most commonly used test to monitor solid phase peptide synthesis is the
Kaiser test. It is simple and rapid and applicable to all N-terminal residues (1).
Any free primary amino group will be indicated by an intense blue color. Hence,
it can be used to monitor both the deprotection and coupling. It is expected that
after each attachment, the Kaiser test will give a negative result. The washing
step in the Kaiser test is critical to avoid producing a false positive result (1). We
performed the Kaiser test to monitor the coupling reaction. The result showed us











- resin. The crude yield of method 1 is 90%, method 2 is 300%.
When we used the standard method to prepare symmetrical anhydride using 2
equivalents of protected amino acid and 1 equivalent of DCC for each run,
coupling results were checked at 3 hours, 4 hours, 5 hours, 6 hours , and 8
hours after the reaction, respectively. Unfortunately, coupling was incomplete
after 8 hours. However, 30 minutes after we added the second equivalent of
preformed anhydride to the reaction chamber, the Kaiser test gave us a negative
result. To get a satisfactory coupling, we decided to use excess amino acid. The
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anhydride was prepared using 4 equivalents of amino acid with 2 equivalents of
DCC. Within an hour of the reaction, the Kaiser test indicated complete coupling.
Conjugation of the carboxylic acid group of the BEC with the amino terminus of
the growing peptide was attempted. Initially, we tried to attach the BEC
symmetrical anhydride molecules, which are the actual intermediates in coupling
reactions, directly to the peptide - resin. This technique has been found to give
the best results of all methods tried in many difficult sequences (1).
Unfortunately, it failed. The reaction was monitored by the Kaiser test for 12
hours. Blue beads and dark blue solutions indicated an unsuccessful coupling.
This could be attributed to the fact that BEC
,
which has a tertiary amino group,
is a big molecule relative to glycine. The N - terminal of glycine could be
sterically hindered from attacking the BEC symmetrical anhydride molecule. The
second approach was an active ester method, wherein an HOBt ester of BEC
was prepared using DCC coupling. Two hours after coupling, the Kaiser test
indicated a successful coupling.
B. Purification of BEC - peptide






gly by cation exchange chromatography.
The results were inconclusive. The effluent fractions were examined by the
ninhydrin identification spray. We did not expect to see any color change for the
18




gly residues. Unfortunately, all the
fractions turned to purple, indicating the presence of some free amino groups.





A. Solid Phase Synthesis of the Benzoylecgonine - Peptide Conjugate with
an enzyme cleavable linker arm
The BEC - peptide could also be cleaved from the resin by a protease. We will
synthesize a peptide in which the first two residues represent a specific site for
the enzyme cleavage. For example, a peptide which has a glycine and
phenylalanine at its carboxy terminal end can be cleaved by chymotrypsin. The
BEC - peptide would then be released into an aqueous solution, where direct
coupling to GO could be attempted using a water soluble coupling reagent such
as diisopropyl carbodiimide.
B. Conjugation of the Benzylecgonine - Peptide to the Enzyme
The purified BEC-peptide will be dissolved in an anhydrous organic solvent,
activated with isobutyl chloroformate, then added to the enzyme solution in
sodium phosphate, 10 mmol/L, pH 7.4 (see fig. 10). The BEC
- peptide is not
soluble in tetrahydrofuran, therefore, NMP is chosen using these criteria: (a) it
must dissolve BEC - peptide; (b) it must not denature the enzyme; (c) it must
have a freezing point below -25C, the temperature for the activation reaction.
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C. Purification of BEC - peptide - GO by Immunoaffinity Chromatography
An antibody towards BEC will be immobilized on Affi - Gel Hz (Bio - Rad
Laboratories) according to the manufacturer's specification. BEC - peptide - GO
will be loaded onto the resin containing immobilized anti - BEC. Following a
high salt wash step, the conjugate will be eluted with citrate buffer (10 mmol/L,
pH 3.0).
D. Characterization of Enzyme - Analyte Conjugate
We will focus mainly on the following three factors in assay performance which
relate specifically to enzyme
- analyte conjugates:
1. Binding of the conjugate to the antibody in the absence of benzoylecgonine.
First, the antibody will be immobilized on microtiter wells using published
methods (19). The wells will be coated with polylysine, which binds
irreversibly to their surface. The carbohydrate portion of the antibody will be
oxidized with sodium periodate. The resulting aldehyde groups will react with
the e-amino groups of the lysine side-chains of the polylysine, thereby
immobilizing the antibody. Then the conjugate will be incubated for 30 min.
with immobilized antibody, the plates washed to remove unbound conjugate,
substrate added for an hour and then the reaction will be quenched after 1
21
hour with 1N sulfuric acid. Absorbance at 405 nm of 1.5 to 2.0 units is
acceptable.
2. Displacement of the bound enzyme - analyte conjugate by the analyte. We
will then incubate the conjugate plus a series of BEC concentrations in a
solid - phase immunoassay format. We will evaluate the data to determine
the midpoint of the calibration curve and the level of non-specific binding.
3. Non - specific binding. A,05 values at BEC concentrations two orders of
magnitude greater than the mid point of the BEC calibration curve ( Aios vs.
logfBEC] ) should be less than 1% of the signal in the absence of BEC.
22
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Fig. 7 Synthesis of Symmetrical Anhydride
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Fig. 8 Synthesis of HOBt Active Esters
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Fig. 10 Synthesis of BEC - GO Conjugate
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Appendix A
Schedule A For BEC - Peptide Synthesis
( method 1 : using Fmoc - gly - resin )
Wash 1 DCM wash, 2 x 30 ml x 2 min.
DMF wash, 3 x 30 ml x 2 min.
Deprotect 30% (v/v) piperidine in DCM, 1 x 30 ml x 3 min., 1 x 30 ml x
7 min.
Wash 2 DMF wash, 3 x 30 ml x 1 min.
DCM wash, 3 x 30 ml x 1 min.
Couple Symmetrical anhydride of Fmoc - amino acid in 50% (v/v)
DCM/DMF, 20 mix 15 min.
DIEA, 1 equivalent to the resin, 30 min. or until monitoring
shows coupling complete
Recouple Repeat steps above
BEC HOBt active ester in DMF, 30 min. or until monitoring
shows coupling complete
Wash 3 DCM wash, 3 x 30 ml x 2 min.
Methanol wash, 2 x 30 ml x 7 min.
Dry under high vacuum for 5 or more hours
Cleavage 50 % or 82.5% (v/v) TFA/water, 20 ml x 120 min.
Etherprecipitation Filter the cleavage mixture using a sintered glass funnel.
Wash the resin several times with the cleavage mixture.
Combine filtrates and bring them to dryness by rotary
evaporation. Add cold ether to precipitate the crude sample.
34
Appendix B
Schedule B For BEC - Peptide Synthesis
( method 2: using Boc - gly - resin )
Wash 1 DCM wash, 2 x 30 ml x 2 min.
Deprotect 50% (v/v) TFA/DCM, 20 ml x 1 5 min.
Wash 2 DCM wash, 2 x 30 ml x 2 min.
DMF wash, 3 x 30 ml x 2 min.
Couple Symmetrical anhydride of Fmoc - amino acid in 50% (v/v)
DCM/DMF, 20 mix 15 min.
DIEA, 1 equivalent to the resin, 30 min. or until monitoring
shows coupling complete
Wash 3 DCM wash, 3 x 30 ml x 2 min.
DMF wash, 3 x 30 ml x 2 min.
Deprotect 30% (v/v) piperidine in DCM, 1 x 30 ml x 3 min., 1 x 30 ml x
7 min.
Wash 4 DMF wash, 3 x 30 ml x 1 min.
DCM wash, 3 x 30 ml x 1 min.
Recouple Repeat steps Wash 1 to Recouple in Schedule A
Wash
Cleavage
DCM wash, 3 x 30 ml x 2 min.
DMF wash, 3 x 30 ml x 2 min.
High quality DMF wash, 3 x 30 ml x 2 min.
Suspend resin in high quality DMF (5 ml per g of resin) with
anhydrous hydrazine (30 equiv. of resin) for 2 days.
Bring the filtrate to dryness by rotary evaporation.
35
